Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | |
| Cash Flows From Operating Activities | |
| Net Income | -9,890 |
| Depreciation Amortization | 10 |
| Other Working Capital | 1,290 |
| Other Operating Activity | 1,670 |
| Operating Cash Flow | $-6,920 |
| Cash Flows From Investing Activities | |
| PPE Investments | -40 |
| Other Investing Activity | -300 |
| Investing Cash Flow | $-340 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 1,570 |
| Financing Cash Flow | $1,570 |
| Exchange Rate Effect | -1,630 |
| Beginning Cash Position | 13,120 |
| End Cash Position | 5,800 |
| Net Cash Flow | $-7,320 |
| Free Cash Flow | |
| Operating Cash Flow | -6,920 |
| Free Cash Flow | -6,920 |